The Global and United States Beta-Nicotinamide Mononucleotide (NMN) Market Report was published by QY Research recently.
Beta-Nicotinamide Mononucleotide (NMN) Market Analysis and Insights
This report focuses on global and United States Beta-Nicotinamide Mononucleotide (NMN) market, also covers the segmentation data of other regions in regional level and county level.
Global key players of beta-nicotinamide mononucleotide (NMN) include GeneHarbor, Herbalmax, Genex Formulas, etc. Asia-Pacific is the largest producer of beta-nicotinamide mononucleotide (NMN), holds a share about 65%, followed by North America, and Europe . In terms of purity, content greater than or equal to 98% is the largest segment, with a share over 90%. And in terms of application, the largest segment is health care products, with a share over 90%.
Beta-Nicotinamide Mononucleotide (NMN) market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Beta-Nicotinamide Mononucleotide (NMN) market will be able to gain the upper hand as they use the report as a powerful resource.
For United States market, this report focuses on the Beta-Nicotinamide Mononucleotide (NMN) market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Full Report Description, Table of Figure, Chart, Free sample, etc. please click
https://us.qyresearch.com/reports/368185/beta-nicotinamide-mononucleotide-nmn
Beta-Nicotinamide Mononucleotide (NMN) Market Segment by Type
Content Greater than or Equal to 98%
Content Less than 98%
Beta-Nicotinamide Mononucleotide (NMN) Market Segment by Application
Health Care Products
Cosmetics
Others
The report on the Beta-Nicotinamide Mononucleotide (NMN) market covers the following region analysis:
North America
Europe
Asia-Pacific
Latin America
Middle East & Africa
The report mentions the prominent market player consisting of:
GeneHarbor
Herbalmax
Genex Formulas
Shinkowa Pharmaceutical
Maac10 Formulas
EffePharm
Bontac
CELFULL
Kingdomway
Key Objectives of This Report
To study and analyze the global Beta-Nicotinamide Mononucleotide (NMN) consumption (value & volume) by key regions/countries, type and application, history data from 2017 to 2022, and forecast to 2028.
To understand the structure of Beta-Nicotinamide Mononucleotide (NMN) market by identifying its various subsegments.
Focuses on the key global Beta-Nicotinamide Mononucleotide (NMN) manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Beta-Nicotinamide Mononucleotide (NMN) with respect to individual growth trends, prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges, and risks).
To project the consumption of Beta-Nicotinamide Mononucleotide (NMN) submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Key Topics Covered
1 Study Coverage
2 Market by Type
3 Market by Application
4 Global Beta-Nicotinamide Mononucleotide (NMN) Competitor Landscape by Company
5 Global Beta-Nicotinamide Mononucleotide (NMN) Market Size by Region
5.1 Global Beta-Nicotinamide Mononucleotide (NMN) Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Beta-Nicotinamide Mononucleotide (NMN) Market Size in Volume by Region (2017-2028)
5.2.1 Global Beta-Nicotinamide Mononucleotide (NMN) Sales in Volume by Region: 2017-2022
5.2.2 Global Beta-Nicotinamide Mononucleotide (NMN) Sales in Volume Forecast by Region (2023-2028)
5.3 Global Beta-Nicotinamide Mononucleotide (NMN) Market Size in Value by Region (2017-2028)
5.3.1 Global Beta-Nicotinamide Mononucleotide (NMN) Sales in Value by Region: 2017-2022
5.3.2 Global Beta-Nicotinamide Mononucleotide (NMN) Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Beta-Nicotinamide Mononucleotide (NMN) Market Size YoY Growth 2017-2028
6.1.2 North America Beta-Nicotinamide Mononucleotide (NMN) Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 United States
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Beta-Nicotinamide Mononucleotide (NMN) Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Beta-Nicotinamide Mononucleotide (NMN) Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 China Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.3 Europe
6.3.1 Europe Beta-Nicotinamide Mononucleotide (NMN) Market Size YoY Growth 2017-2028
6.3.2 Europe Beta-Nicotinamide Mononucleotide (NMN) Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Beta-Nicotinamide Mononucleotide (NMN) Market Size YoY Growth 2017-2028
6.4.2 Latin America Beta-Nicotinamide Mononucleotide (NMN) Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.4.6 Colombia
6.5 Middle East and Africa
6.5.1 Middle East and Africa Beta-Nicotinamide Mononucleotide (NMN) Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Beta-Nicotinamide Mononucleotide (NMN) Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 GeneHarbor
7.1.1 GeneHarbor Corporation Information
7.1.2 GeneHarbor Description and Business Overview
7.1.3 GeneHarbor Beta-Nicotinamide Mononucleotide (NMN) Sales, Revenue and Gross Margin (2017-2022)
7.1.4 GeneHarbor Beta-Nicotinamide Mononucleotide (NMN) Products Offered
7.1.5 GeneHarbor Recent Development
7.2 Herbalmax
7.2.1 Herbalmax Corporation Information
7.2.2 Herbalmax Description and Business Overview
7.2.3 Herbalmax Beta-Nicotinamide Mononucleotide (NMN) Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Herbalmax Beta-Nicotinamide Mononucleotide (NMN) Products Offered
7.2.5 Herbalmax Recent Development
7.3 Genex Formulas
7.3.1 Genex Formulas Corporation Information
7.3.2 Genex Formulas Description and Business Overview
7.3.3 Genex Formulas Beta-Nicotinamide Mononucleotide (NMN) Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Genex Formulas Beta-Nicotinamide Mononucleotide (NMN) Products Offered
7.3.5 Genex Formulas Recent Development
7.4 Shinkowa Pharmaceutical
7.4.1 Shinkowa Pharmaceutical Corporation Information
7.4.2 Shinkowa Pharmaceutical Description and Business Overview
7.4.3 Shinkowa Pharmaceutical Beta-Nicotinamide Mononucleotide (NMN) Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Shinkowa Pharmaceutical Beta-Nicotinamide Mononucleotide (NMN) Products Offered
7.4.5 Shinkowa Pharmaceutical Recent Development
7.5 Maac10 Formulas
7.5.1 Maac10 Formulas Corporation Information
7.5.2 Maac10 Formulas Description and Business Overview
7.5.3 Maac10 Formulas Beta-Nicotinamide Mononucleotide (NMN) Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Maac10 Formulas Beta-Nicotinamide Mononucleotide (NMN) Products Offered
7.5.5 Maac10 Formulas Recent Development
7.6 EffePharm
7.6.1 EffePharm Corporation Information
7.6.2 EffePharm Description and Business Overview
7.6.3 EffePharm Beta-Nicotinamide Mononucleotide (NMN) Sales, Revenue and Gross Margin (2017-2022)
7.6.4 EffePharm Beta-Nicotinamide Mononucleotide (NMN) Products Offered
7.6.5 EffePharm Recent Development
7.7 Bontac
7.7.1 Bontac Corporation Information
7.7.2 Bontac Description and Business Overview
7.7.3 Bontac Beta-Nicotinamide Mononucleotide (NMN) Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Bontac Beta-Nicotinamide Mononucleotide (NMN) Products Offered
7.7.5 Bontac Recent Development
7.8 CELFULL
7.8.1 CELFULL Corporation Information
7.8.2 CELFULL Description and Business Overview
7.8.3 CELFULL Beta-Nicotinamide Mononucleotide (NMN) Sales, Revenue and Gross Margin (2017-2022)
7.8.4 CELFULL Beta-Nicotinamide Mononucleotide (NMN) Products Offered
7.8.5 CELFULL Recent Development
7.9 Kingdomway
7.9.1 Kingdomway Corporation Information
7.9.2 Kingdomway Description and Business Overview
7.9.3 Kingdomway Beta-Nicotinamide Mononucleotide (NMN) Sales, Revenue and Gross Margin (2017-2022)
7.9.4 Kingdomway Beta-Nicotinamide Mononucleotide (NMN) Products Offered
7.9.5 Kingdomway Recent Development
Any questions about the report, please click
https://us.qyresearch.com/reports/368185/beta-nicotinamide-mononucleotide-nmn
Customization of the Report:
This report can be customized to meet the client’s requirements. Please contact with us (global@qyresearch.com), who will ensure that you get a report that suits your needs.
Company Profiles:
QYResearch founded in California, USA in 2007. It is a leading global market research and consulting company. With over 15 years’ experience and professional research team in various cities over the world, QY Research focuses on management consulting, database and seminar services, IPO consulting, industry chain research and customized research to help our clients in providing non-linear revenue model and make them successful. We are globally recognized for our expansive portfolio of services, good corporate citizenship, and our strong commitment to sustainability. Up to now, we have cooperated with more than 59,000 clients across five continents. Let’s work closely with you and build a bold and better future.
Contact Us
QY Research
E-mail: global@qyresearch.com
Tel: +1-626-842-1666(US) +852-5808-0956 (HK)
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
Website: https://us.qyresearch.com